NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $589,000 | -83.1% | 8,747 | -78.8% | 0.06% | -70.5% |
| Q4 2019 | $3,481,000 | -36.5% | 41,302 | -43.6% | 0.20% | -23.4% |
| Q3 2019 | $5,478,000 | +70.1% | 73,255 | +43.8% | 0.26% | +82.5% |
| Q2 2019 | $3,220,000 | +50.3% | 50,925 | +14.5% | 0.14% | +72.3% |
| Q1 2019 | $2,143,000 | -74.9% | 44,490 | -72.6% | 0.08% | -66.8% |
| Q3 2018 | $8,521,000 | +27.9% | 162,620 | -23.6% | 0.25% | +22.5% |
| Q2 2018 | $6,663,000 | +109.0% | 212,875 | +45.6% | 0.20% | +100.0% |
| Q1 2018 | $3,188,000 | +1.3% | 146,225 | -6.1% | 0.10% | +6.2% |
| Q4 2017 | $3,146,000 | +55.7% | 155,725 | +53.0% | 0.10% | +50.0% |
| Q3 2017 | $2,021,000 | +80.6% | 101,795 | +57.4% | 0.06% | +113.3% |
| Q2 2017 | $1,119,000 | – | 64,685 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |